Cover image for Drug approvals Critical updates in an ever-changing environment  Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...

Becker’s Payer Issues

Cover image for Summer 2023 Prime Therapeutics Report Gene Therapy Update Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pt_summer_report_pdf?fr=xKAE9_zU1NQ Explore the report ...

Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage

cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...

Drug Approvals Quarterly Update: October 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Prime is honored to announce its information technology (IT) department’s Quality Excellence Center (QEC), together with Infosys, received the North American Software Testing Award (NASTA) for Best...

Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.

Recognition benchmarks disability workplace inclusion against other companies

From cutting-edge system solutions to powerful stakeholder partnerships, the Medicaid Enterprise Systems Conference delivered key insights and connections that will shape health care modernization...

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe

Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

Specialty Pharmacy Continuum

Members on cancer care journey laud Prime’s integrated clinic-to-pharmacy experience

Prime leaders discuss rebates, reporting and other state issues at hybrid conference in Chicago.

Experts in Medicaid pharmacy delivery engage in timely discussion of states’ access and cost challenges and offer Prime’s solutions to fill resource gaps and improve health outcomes for people...

Job-seeking platform recognizes Prime’s leadership in championing flexible work

Joseph Leach, M.D., senior vice president and chief medical officer at Prime Therapeutics/Magellan Rx Management, shares more about the RTBC electronic prescription decision support tool

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Reprinted with AIS Health permission from the November 2024 issue of Radar on Specialty Pharmacy

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”

Prime celebrates 25th anniversary, and Magellan Rx celebrates 10th anniversary

AIS Health

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

A look at the specialty landscape and how Prime delivers value to employers

What works and what doesn’t

Managed Healthcare Executive

cover image for Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights Prime Therapeutics /trending-topics-drug-approvals-june-2025-1 Prime Therapeutics’...